• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MED REL MEDTRONIC PUERTO RICO INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MED REL MEDTRONIC PUERTO RICO INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 3058
Device Problem Pocket Stimulation (1463)
Patient Problems Therapeutic Effects, Unexpected (2099); Anxiety (2328); Insufficient Information (4580)
Event Date 11/10/2020
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stim and gastrointestinal/ pelvic floor.It was reported that the patient just received a new implant today and said that the stimulation is in the butt area not in the front.Patient said that the rep said to program so that it is midline to the vaginal area.Patient said that the rep reviewed everything very quickly right after the procedure when patient recovering from anesthesia and hightailed it out.Patient is very upset and said that, with the exception of program 3, the stimulation sensation on all other programs was in her back where the neurostimulator was placed.Patient said that program 3 is a little forward.Patient again, said is very upset that this wasn't programmed correctly beforehand.The issue was not resolved through troubleshooting.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a health care professional (hcp) via a manufacturer representative (rep).The rep reported that the cause of the stimulation being felt at the neurostimulator site as well as what most likely caused or contributed to the stimulation being felt at the neurostimulator site was unknown.In response to the inquiry for what steps had been or would be taken to resolve the issue and if the issue had been resolved, the rep replied that the patient was currently on program 3 and it was felt approximately in their ¿bicycle seat area/butt.¿ the rep reported that the patient had been scheduled for a 7 am surgery and that they had arrived at the surgery center at around 6 am.The rep stated that the patient had been thoroughly educated before their procedure with plenty of time for review and questions.The rep stated that post-operatively they had spent time with the patient again, answering the patient¿s questions and re-educating.The rep also mentioned that the patient had stated multiple times that they were anxious.No further complications were reported at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM II
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC MED REL MEDTRONIC PUERTO RICO
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key10836789
MDR Text Key219368801
Report Number3004209178-2020-19950
Device Sequence Number1
Product Code EZW
Combination Product (y/n)N
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 11/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2014
Device Model Number3058
Device Catalogue Number3058
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/10/2020
Initial Date FDA Received11/13/2020
Supplement Dates Manufacturer Received11/13/2020
Supplement Dates FDA Received11/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age50 YR
-
-